Status:
COMPLETED
GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-90 years
Phase:
PHASE3
Brief Summary
Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer. The GF-GS 01 study, sponsored by a National Hospital Research Program, compares this new surgica...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Women older than 18 years with clinically node-negative operable unifocal N0 breast cancer (clinical tumour size \< 30 mm).
- Written consent is obtained from all patients before randomization.
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
1627 Patients enrolled
Trial Details
Trial ID
NCT00144898
Start Date
July 1 2003
End Date
June 1 2012
Last Update
May 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alain LEIZOROVICZ
Lyon, France, 69376